Four major wins for our Bird & Bird IP Team at the Annual Managing IP EMEA Awards

Congratulations were in order for Bird & Bird's international IP team last night at the European MIP Award ceremony in London. The team was nominated for 21 categories across our European offices, more than any other firm nominated, and took home:

• Impact Case of the Year: Actavis Group PTC EHF & Ors v ICOS Corporation & Anor
• Impact Case of the Year: Warner Music UK Ltd & Anor v Tunein Inc
• Patent Contentious Firm of the Year - Germany
• Trade Mark Contentious Firm of the Year - Europe

These wins, all in very different categories and different areas of IP Law, really demonstrate our solid strength across all areas of IP, proving that we are truly a one-stop-shop.

Christian Harmsen, co-Head of the firm's international IP Group was attending on the night and said "This is a great win for our international practice, and showcases our team both nationally and internationally. All have been working hard to steer clients through current and future challenges. Christian went on to congratulate our German patents team, who are “once again proven as market leaders with an exceptional group of creative patent litigators and technically focussed patent attorneys” and our UK team "for their important role in two of the largest reported cases on the copyright and patents front in recent years"

Our group has been successful at every ceremony since the inception of these awards.


News & Deals

More News & Deals
Deal Bird & Bird advises Theon on the acquisition of Kappa Optronics

Aug 12 2025

Read More
Deal Bird & Bird advises shareholders of The Payments Association on partnership with Nineteen Group

Aug 07 2025

Read More
News Bird & Bird boosts Dispute Resolution team in Singapore

Aug 06 2025

Read More
Deal Bird & Bird acts for Cornerstone Investors in US$140m placing by Rockhopper Exploration

Aug 06 2025

Read More
Deal Bird & Bird advises ACTUM Digital on Strategic Acquisition of Kuehlhaus AG

Aug 05 2025

Read More
News Bird & Bird Advises Ratiopharm in Landmark Xarelto Patent Revocation Case

Aug 01 2025

Read More

Related capabilities